XM does not provide services to residents of the United States of America.

Australian shares log record closing high on healthcare, IT boost



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Australian shares log record closing high on healthcare, IT boost</title></head><body>

Australia inflation data due later in the week

New Zealand stocks hit level unseen since Oct 2021

New Zealand cenbank expected to cut rates on Wednesday

Updates to close

By Adwitiya Srivastava

Nov 25 (Reuters) -Australian shares posted a record closing high on Monday, led by healthcare and technology stocks, as investors cheered the nomination of Scott Bessent as the next U.S. Treasury secretary, expecting he would be a voice for markets.

The S&P/ASX 200 index .AXJO rose 0.3% to 8,417.6, extending its gains to a second session.

U.S. President-elect Donald Trump said on Friday he would nominate prominent investor Bessent as U.S. Treasury secretary, leading to some strategists saying his appointment could reduce the chance of severe tariffs.

"We can see that Trump's nomination of Scott Bessent is having a positive impact on markets. U.S. futures are in the green," said Josh Gilbert, a market analyst at eToro AUS Capital.

"Investors saw the move as positive, with the expectation that he would prioritise economic and market stability."

In Australia, investors were awaiting key inflation data and comments from Reserve Bank of Australia (RBA) Governor Michelle Bullock, due later in the week, for further clarity on the central bank's monetary policy stance.

In Sydney, healthcare stocks .AXHJ climbed 1.3%. CSL CSL.AX, one of the country's priciest stocks, jumped 1.7%.

Technology stocks .AXIJ added to the gains, rising 0.9% after their Wall Street peers closed higher on Friday. .N

On the other hand, financial stocks .AXFJ slipped 0.2%, led by a 1.3% fall in ANZ Group ANZ.AX. Westpac WBC.AX fell 1.2%, while Commonwealth Bank of Australia CBA.AX rose 0.7%.

"We're seeing some profit-taking in the financial sector. CBA hit a record high last week, while Westpac was trading at 52-week highs," Gilbert said.

Gold stocks .AXGD fell about 1.3% as bullion prices eased. GOL/

New Zealand's benchmark S&P/NZX 50 index .NZ50 rose 1.2% to 13,196.08, its highest since early October 2021, on expectation of an interest rate cut later in the week.

The country's central bank is expected to cut rates by 50 basis points on Wednesday, a Reuters Poll showed.



Reporting by Adwitiya Srivastava in Bengaluru; Editing by Subhranshu Sahu

For more information on DIARIES & DATA: U.S. earnings diary RESF/US Wall Street Week Ahead .N/O Global Economy Week Ahead DATA/ ................................................................ For latest top breaking news across all markets NEWS1
</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.